Summary
Definition
History and exam
Key diagnostic factors
- presença de fatores de risco
- exposição a um orthoebolavirus nos últimos 21 dias
- febre
- mialgia
- hiperemia conjuntival
Other diagnostic factors
- fadiga
- anorexia
- diarreia
- vômitos
- cefaleia intensa
- dor abdominal ou pirose
- tosse, dispneia, dor torácica
- faringite
- prostração
- taquipneia
- exantema maculopapular
- sangramento
- hepatomegalia
- linfadenopatia
- soluços
- taquicardia
- hipotensão
- sinais neurológicos
Risk factors
- morar, trabalhar ou chegar de uma área endêmica nos últimos 21 dias
- contato com fluidos corporais infectados
- exposição ocupacional
- hábito de comer carne de caça ou consumo de carne de animais infectados (ou potencialmente infectados)
- bioterrorismo
Diagnostic tests
1st tests to order
- reação em cadeia da polimerase via transcriptase reversa (RT-PCR)
- investigações para malária
Tests to consider
- níveis de eletrólitos séricos
- creatinina sérica e ureia
- lactato sanguíneo
- gasometria arterial
- Hemograma completo
- exames de coagulação
- urinálise
- TFHs
- nível de amilase sérica
- glicemia sérica
- hemoculturas
- ELISA de captura de antígeno
- anticorpos do tipo imunoglobulina G (IgG) e imunoglobulina M (IgM)
- radiografia torácica
Treatment algorithm
Contributors
Authors
Catherine F. Houlihan, MSc, MB ChB, MRCP, DTM&H
Clinical Lecturer
University College London
Honorary Clinical Lecturer
London School of Hygiene and Tropical Medicine
London
UK
Disclosures
CFH has been on a scientific advisory board for Valneva regarding Chikungunya vaccines.
Manuel Fenech, MD, MRCP, DTM&H
Specialist Trainee in Infectious Diseases
Royal Liverpool University Hospital
Liverpool
UK
Disclosures
MF declares that he has no competing interests.
Tom E. Fletcher, MBE, MBChB, MRCP, DTM&H
Wellcome Trust/MoD Research Fellow
Liverpool School of Tropical Medicine
Liverpool
UK
Disclosures
TEF is an author of a number of references cited in this monograph. TEF is a consultant/expert panel member to the World Health Organization, and is funded by the UK Surgeon General and the Wellcome Trust. TEF has received research grants from the Medical Research Council and the UK Public Health Rapid Support Team (UK-PHRST).
Acknowledgements
Dr Catherine F. Houlihan, Dr Manuel Fenech, and Dr Tom E. Fletcher would like to thank Dr Nicholas J. Beeching, a previous contributor to this topic, and Dr Colin Brown (Infectious Disease Lead, Kings Sierra Leone Partnership) for his helpful comments and insights.
Disclosures
NJB was partially supported by the National Institute of Health Research Health Protection Unit in Emerging and Zoonotic Infections at the University of Liverpool and Public Health England. NJB is an author of references cited in this topic. CB declares that he has no competing interests.
Peer reviewers
William A. Petri, Jr, MD, PhD, FACP
Wade Hampton Frost Professor of Epidemiology
Professor of Medicine, Microbiology, and Pathology
Chief
Division of Infectious Diseases and International Health
University of Virginia
Charlottesville
VA
Disclosures
WAP declares that he has no competing interests.
Luis Ostrosky-Zeichner, MD, FACP, FIDSA, FSHEA
Professor of Medicine and Epidemiology
UT Health Medical School
Medical Director of Epidemiology
Memorial Hermann Texas Medical Center
Houston
TX
Disclosures
LO-Z declares that he has no competing interests.
Stephen Mepham, MRCP (UK), FRCPATH, DTM&H, MD
Consultant in Microbiology and Infectious Diseases
Royal Free London NHS Foundation Trust
London
UK
Disclosures
SM declares that he has no competing interests.
References
Key articles
World Health Organization. Clinical care for survivors of Ebola virus disease: interim guidance. Apr 2016 [internet publication].Full text
World Health Organization. Guidelines for the management of pregnant and breastfeeding women in the context of Ebola virus disease. 2020 [internet publication].Full text
World Health Organization. Infection prevention and control guideline for Ebola and Marburg disease. Aug 2023 [internet publication].Full text
World Health Organization. Optimized supportive care for Ebola virus disease. July 2019 [internet publication].Full text
Lamontagne F, Fowler RA, Adhikari NK, et al. Evidence-based guidelines for supportive care of patients with Ebola virus disease. Lancet. 2018 Feb 17;391(10121):700-8.Full text Abstract
World Health Organization. Clinical management of patients with viral haemorrhagic fever: a pocket guide for the front-line health worker. Feb 2016 [internet publication].Full text
World Health Organization. Therapeutics for Ebola virus disease - Democratic Republic of the Congo. Aug 2022 [internet publication].Full text
Reference articles
A full list of sources referenced in this topic is available here.
Use of this content is subject to our disclaimer